Synthekine Strengthens Leadership with Board of Directors Expansion and Scientific Advisory Board Formation

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Pablo Cagnoni, M.D., to its board of directors. Dr. Cagnoni brings to Synthekine extensive leadership experience in the biotech industry and a successful track record of oncology drug development. The company also announced the formation of its scientific advisory board to help guide the company’s extensive cytokine engineering efforts. “Synthekine has made si

Click to view original post